| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 37 |
| 1 | ETANERCEPT | 30 |
| 2 | ERGOCALCIFEROL | 24 |
| 3 | ASPIRIN | 22 |
| 4 | DUPILUMAB | 21 |
| 5 | ASPIRIN 325 MG | 20 |
| 6 | ASPIRIN 81 MG | 20 |
| 7 | PREDNISONE | 19 |
| 8 | IBUPROFEN | 17 |
| 9 | METHOTREXATE SODIUM | 17 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ANHYDROUS CITRIC ACID, SODIUM BICARBONATE, AND ASPIRIN | 1 | 0.0714 |
| 1 | SETMELANOTIDE | 11 | 0.0386 |
| 2 | TOVORAFENIB | 6 | 0.0184 |
| 3 | FLUORIDE TOOTHPASTE | 1 | 0.0050 |
| 4 | HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE | 1 | 0.0047 |
| 5 | .ALPHA.-TOCOPHEROL ACETATE, DL-, ASCORBIC ACID, CYANOCOBALAMIN, FOLIC ACID, NIACIN, PYRIDOXINE, RIBOFLAVIN, SODIUM FLUORIDE, THIAMINE MONONITRATE, VITAMIN A AND VITAMIN D | 1 | 0.0045 |
| 6 | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | 1 | 0.0021 |
| 7 | RIPRETINIB | 9 | 0.0017 |
| 8 | TEBENTAFUSP | 1 | 0.0017 |
| 9 | PEXIDARTINIB HYDROCHLORIDE | 1 | 0.0014 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 46 |
| 1 | Corticosteroid [EPC] | 42 |
| 2 | Kinase Inhibitor [EPC] | 39 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 35 |
| 4 | Benzodiazepine [EPC] | 28 |
| 5 | Provitamin D2 Compound [EPC] | 24 |
| 6 | Interleukin-23 Antagonist [EPC] | 23 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 23 |
| 8 | Interleukin-4 Receptor alpha Antagonist [EPC] | 21 |
| 9 | Factor Xa Inhibitor [EPC] | 16 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Melanocortin 4 Receptor Agonist [EPC] | 11 | 0.0386 |
| 1 | Vitamin B6 Analog [EPC] | 1 | 0.0028 |
| 2 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 1 | 0.0017 |
| 3 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 4 | Provitamin D2 Compound [EPC] | 24 | 0.0008 |
| 5 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 1 | 0.0006 |
| 6 | Interferon alfa-2b [EPC] | 1 | 0.0005 |
| 7 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 8 | Interleukin-17A Antagonist [EPC] | 16 | 0.0004 |
| 9 | Anthelmintic [EPC] | 1 | 0.0003 |